Value through Innovation08 April 2014

Examples of Partnerships

We view partnership as essential for our success. We interact with open communication and a team approach. We commit ourselves to the projects we share with partners to make their products a success.

Cardiometabolic

DeveloGen

DeveloGen  

Indication: Metabolic Diseases
Development Stage: Pre-clinical
Agreement & Year: Asset Purchase and Collaboration Agreement, 2009

EVEC, Inc

EVEC, Inc

Indication: Metabolic Diseases
Development Stage: Pre-clinical
Agreement & Year: License Agreement, 2008

Lilly

Lilly

Indication: Metabolic Diabetes
Development Stage: Clinical
Agreement & Year: Global Strategic Alliance, 2011

Neurocrine

Neurocrine

Indication: Metabolic Diseases
Development Stage: Pre-clinical
Agreement & Year: Research Collaboration and License Agreement, 2010

Vitae

Vitae

Indication: Metabolic Diseases
Development Stage: Pre-clinical
Agreement & Year: License Agreement, 2007

Zealand Pharma

Zealand Pharma 

Indication: Type 2 Diabetes and obesity
Development Stage: Pre-clinical/Clinical
Agreement & Year: Global License and Collaboration Agreement, 2011

Central Nervous System

Ablynx

Ablynx  

Indication: Alzheimer's Disease
Development Stage: Discovery
Agreement & Year: Research Collaboration and License Agreement, 2007

BioCrea

BioCrea 

Indication: CNS Diseases
Development Stage: Pre-clinical
Agreement & Year: Asset Purchase and Licensing Agreement, 2012

Biolipox Orexo

Biolipox Orexo  

Indication: CNS (chronic pain)
Development Stage: Pre-clinical
Agreement & Year: Research Collaboration and License Agreement, 2005

Vitae

Vitae

Indication: Alzheimer's Disease
Development Stage: Pre-clinical
Agreement & Year: Research Collaboration, 2009

Oncology

Forma Therapeutics

Forma Therapeutics 

Indication: Oncology
Development Stage: Discovery
Agreement & Year: Research and Development Collaboration, 2012 

Micromet

Micromet

Indication: Oncology/Multiple Myeloma
Development Stage: Discovery
Agreement & Year: Global Collaboration, 2010

Qiagen

Qiagen 

Indication: Companion diagnostic for detecting EGFR mutations
Development Stage: Clinical
Agreement & Year: Companion Diagnostic, 2009

Priaxon

Priaxon  

Indication: Oncology
Development Stage: Pre-clinical
Agreement & Year: Collaboration and License Agreement, 2009

Respiratory

Actimis

Actimis  

Indication: Asthma, Allergic rhinitis
Development Stage: Development
Agreement & Year: Share Purchase and License Agreement, 2008  

Funxional Therapeutics, Ltd.

Funxional Therapeutics, Ltd.  

Indication: Inflammatory Diseases (Asthma, COPD)
Development Stage: Phase II
Agreement & Year: License Agreement, 2012  

Technologies

4-Antibody

4-Antibody

Indication: Therapeutic Antibodies
Development Stage: Discovery
Agreement & Year: Research Collaboration, 2010

Ablynx

Ablynx  

Indication: Multiple therapeutic areas
Development Stage: Discovery
Agreement & Year: Research Collaboration and License Agreement, 2007

Ensemble Therapeutics Corporation

Ensemble Therapeutics Corporation

Indication: Multiple therapeutic areas
Development Stage: Discovery
Agreement & Year: Research Collaboration, 2012

Evotec

Evotec

Indication: GPCR
Development Stage: Discovery
Agreement & Year: Research Alliance, 2004

f-star

f-star

Indication: Therapeutic Antibody
Development Stage: Discovery
Agreement & Year: Collaboration and License Agreement, 2010

Harvard University

Harvard University 

Indication: Multiple therapeutic areas
Development Stage: Discovery
Agreement & Year: Research Collaboration, 2012 

Healthrageous Inc.

Healthrageous Inc. 

Indication: Type II Diabetes
Development Stage: Discovery
Agreement & Year: Research Collaboration, 2012 

Macrogenics

Macrogenics

Indication: DART™-Based Antibody Therapeutics
Development Stage: Discovery
Agreement & Year: Global Alliance, 2010

Nuevolution A/S

Nuevolution A/S  

Indication: Multiple therapeutic areas
Development Stage: Discovery
Agreement & Year: Research Collaboration, 2011

Polyphor Ltd.

Polyphor Ltd.

Indication: Multiple therapeutic areas
Development Stage: Discovery
Agreement & Year: Research Collaboration and License Agreement, 2012

Xencor

Xencor

Indication: Antibody Technology
Development Stage: Pre-clinical/Clinical
Agreement & Year: License Agreement, 2007